Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Epigenetic Landscape of Acute Myeloid Leukemia
Emma Conway O’Brien, Steven M. Prideaux, Timothy Chevassut
Advances in Hematology (2014) Vol. 2014, pp. 1-15
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Isocitrate dehydrogenase mutations in myeloid malignancies
Bruno C. Medeiros, Amir T. Fathi, Courtney D. DiNardo, et al.
Leukemia (2016) Vol. 31, Iss. 2, pp. 272-281
Open Access | Times Cited: 311
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Nicolas Duployez, Alice Marceau‐Renaut, Nicolas Boissel, et al.
Blood (2016) Vol. 127, Iss. 20, pp. 2451-2459
Open Access | Times Cited: 218
Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis.
Francisco Alejandro Lagunas‐Rangel, Venice Chávez‐Valencia, Miguel Ángel Gómez‐Guijosa, et al.
PubMed (2017) Vol. 11, Iss. 4, pp. 328-339
Closed Access | Times Cited: 129
Targeting cell cycle regulators in hematologic malignancies
Eiman Aleem, R.J. Arceci
Frontiers in Cell and Developmental Biology (2015) Vol. 3
Open Access | Times Cited: 115
5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy
Aparna Vasanthakumar, Lucy A. Godley
Cancer Genetics (2015) Vol. 208, Iss. 5, pp. 167-177
Closed Access | Times Cited: 92
When the good go bad: Mutant NPM1 in acute myeloid leukemia
Preethi Kunchala, Sudhakiranmayi Kuravi, Roy A. Jensen, et al.
Blood Reviews (2017) Vol. 32, Iss. 3, pp. 167-183
Closed Access | Times Cited: 87
Epigenetics in Cancer: A Hematological Perspective
Maximilian Stahl, Nathan Kohrman, Steven D. Gore, et al.
PLoS Genetics (2016) Vol. 12, Iss. 10, pp. e1006193-e1006193
Open Access | Times Cited: 84
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC
Chenying Li, Lei Dong, Rui Su, et al.
Haematologica (2019) Vol. 105, Iss. 1, pp. 148-160
Open Access | Times Cited: 57
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions
Tae Kon Kim, Steven D. Gore, Amer M. Zeidan
Seminars in Hematology (2015) Vol. 52, Iss. 3, pp. 172-183
Open Access | Times Cited: 61
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, et al.
Biology of Blood and Marrow Transplantation (2015) Vol. 22, Iss. 1, pp. 61-70
Open Access | Times Cited: 54
The role of mutations in epigenetic regulators in myeloid malignancies
Brittany A. Woods, Ross L. Levine
Immunological Reviews (2014) Vol. 263, Iss. 1, pp. 22-35
Open Access | Times Cited: 53
Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia
Mengning Wang, Chuanwei Yang, Le Zhang, et al.
Stem Cells International (2017) Vol. 2017, pp. 1-11
Open Access | Times Cited: 51
Epigenetics and Evolution
Peter Saunders
Human Development (2017) Vol. 60, Iss. 2-3, pp. 81-94
Closed Access | Times Cited: 49
Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
Anna Eriksson, Andreas Lennartsson, Sören Lehmann
Experimental Hematology (2015) Vol. 43, Iss. 8, pp. 609-624
Open Access | Times Cited: 48
Epigenetic alterations in acute myeloid leukemias
Parinaz Mehdipour, Fabio Santoro, Saverio Minucci
FEBS Journal (2014) Vol. 282, Iss. 9, pp. 1786-1800
Open Access | Times Cited: 42
Using zebrafish models of leukemia to streamline drug screening and discovery
Adam P Deveau, Victoria L. Bentley, Jason N. Berman
Experimental Hematology (2016) Vol. 45, pp. 1-9
Open Access | Times Cited: 32
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome
Lacey Williams, Kimberley Doucette, Judith E. Karp, et al.
Bone Marrow Transplantation (2021) Vol. 56, Iss. 7, pp. 1535-1549
Closed Access | Times Cited: 27
Investigation methylation status of tumor suppressor gene
Bita Rahmani, Shahrbano Rostami, Yousef Mortazavi, et al.
PubMed (2025) Vol. 14, Iss. 2, pp. 149-156
Closed Access
The molecular basis of haematological malignancies
Meng Wang, Niccolò Bolli, George S. Vassiliou
(2025), pp. 121-141
Closed Access
Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia
Yanfang Tao, Lixiao Xu, Jun Lu, et al.
Journal of Experimental & Clinical Cancer Research (2015) Vol. 34, Iss. 1
Open Access | Times Cited: 33
Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
Nicolas Duployez, Christophe Willekens, Alice Marceau‐Renaut, et al.
Expert Review of Hematology (2014) Vol. 8, Iss. 1, pp. 43-56
Closed Access | Times Cited: 31
Drugging the unfolded protein response in acute leukemias
Behzad Kharabi Masouleh, Éric Chevet, Jens Panse, et al.
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Activating STING1-dependent immune signaling inTP53mutant and wild-type acute myeloid leukemia
Aksinija A. Kogan, Michael J. Topper, Anna J. Dellomo, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 27
Open Access | Times Cited: 15
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors
Melisa Tecik, Aysun Adan
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 6, pp. 719-751
Open Access | Times Cited: 3
miR‐155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group
Ranjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Pediatric Blood & Cancer (2016) Vol. 63, Iss. 12, pp. 2096-2103
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top